Optimal first trimester preeclampsia prediction

A comparison of multimarker algorithm, risk profiles and their sequential application

R. Gabbay-Benziv, N. Oliveira, Ahmet Baschat

Research output: Contribution to journalArticle

Abstract

Objective: To compare performance of multimarker algorithm, risk profiles and their sequential application in prediction of preeclampsia and determining potential intervention targets. Study Design: Maternal characteristics, ultrasound variables and serum biomarkers were collected prospectively at first trimester. Univariate analysis identified preeclampsia associated variables followed by logistic regression analysis to determine the prediction rule. Combined characteristics of the cardiovascular, metabolic and the personal risk factors were compared to the multimarker algorithm and the sequential application of both methods. Results: Out of 2433 women, 108 developed preeclampsia (4.4%). Probability scores considering nulliparity, prior preeclampsia, body mass index, diastolic blood pressure and placental growth factor had an area under the receiver operating characteristic curve 0.784 (95% CI=0.721-0.847). While the multimarker algorithm had the lowest false negative rate, sequential application of cardiovascular and metabolic risk profiles in screen positives reduced false positives by 26% and identified blood pressure and metabolic risk in 49/54 (91%) women with subsequent preeclampsia as treatable risk factors. Conclusion: Sequential application of a multimarker algorithm followed by determination of treatable risk factors in screen positive women is the optimal approach for first trimester preeclampsia prediction and identification of women that may benefit from targeted metabolic or cardiovascular treatment.

Original languageEnglish (US)
Pages (from-to)34-39
Number of pages6
JournalPrenatal Diagnosis
Volume36
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

First Pregnancy Trimester
Pre-Eclampsia
Blood Pressure
Metabolome
Parity
ROC Curve
Intercellular Signaling Peptides and Proteins
Body Mass Index
Biomarkers
Logistic Models
Regression Analysis
Mothers
Serum

ASJC Scopus subject areas

  • Genetics(clinical)
  • Obstetrics and Gynecology

Cite this

Optimal first trimester preeclampsia prediction : A comparison of multimarker algorithm, risk profiles and their sequential application. / Gabbay-Benziv, R.; Oliveira, N.; Baschat, Ahmet.

In: Prenatal Diagnosis, Vol. 36, No. 1, 01.01.2016, p. 34-39.

Research output: Contribution to journalArticle

@article{48537aad0f1b4222a9191a96998bc74a,
title = "Optimal first trimester preeclampsia prediction: A comparison of multimarker algorithm, risk profiles and their sequential application",
abstract = "Objective: To compare performance of multimarker algorithm, risk profiles and their sequential application in prediction of preeclampsia and determining potential intervention targets. Study Design: Maternal characteristics, ultrasound variables and serum biomarkers were collected prospectively at first trimester. Univariate analysis identified preeclampsia associated variables followed by logistic regression analysis to determine the prediction rule. Combined characteristics of the cardiovascular, metabolic and the personal risk factors were compared to the multimarker algorithm and the sequential application of both methods. Results: Out of 2433 women, 108 developed preeclampsia (4.4{\%}). Probability scores considering nulliparity, prior preeclampsia, body mass index, diastolic blood pressure and placental growth factor had an area under the receiver operating characteristic curve 0.784 (95{\%} CI=0.721-0.847). While the multimarker algorithm had the lowest false negative rate, sequential application of cardiovascular and metabolic risk profiles in screen positives reduced false positives by 26{\%} and identified blood pressure and metabolic risk in 49/54 (91{\%}) women with subsequent preeclampsia as treatable risk factors. Conclusion: Sequential application of a multimarker algorithm followed by determination of treatable risk factors in screen positive women is the optimal approach for first trimester preeclampsia prediction and identification of women that may benefit from targeted metabolic or cardiovascular treatment.",
author = "R. Gabbay-Benziv and N. Oliveira and Ahmet Baschat",
year = "2016",
month = "1",
day = "1",
doi = "10.1002/pd.4707",
language = "English (US)",
volume = "36",
pages = "34--39",
journal = "Prenatal Diagnosis",
issn = "0197-3851",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Optimal first trimester preeclampsia prediction

T2 - A comparison of multimarker algorithm, risk profiles and their sequential application

AU - Gabbay-Benziv, R.

AU - Oliveira, N.

AU - Baschat, Ahmet

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Objective: To compare performance of multimarker algorithm, risk profiles and their sequential application in prediction of preeclampsia and determining potential intervention targets. Study Design: Maternal characteristics, ultrasound variables and serum biomarkers were collected prospectively at first trimester. Univariate analysis identified preeclampsia associated variables followed by logistic regression analysis to determine the prediction rule. Combined characteristics of the cardiovascular, metabolic and the personal risk factors were compared to the multimarker algorithm and the sequential application of both methods. Results: Out of 2433 women, 108 developed preeclampsia (4.4%). Probability scores considering nulliparity, prior preeclampsia, body mass index, diastolic blood pressure and placental growth factor had an area under the receiver operating characteristic curve 0.784 (95% CI=0.721-0.847). While the multimarker algorithm had the lowest false negative rate, sequential application of cardiovascular and metabolic risk profiles in screen positives reduced false positives by 26% and identified blood pressure and metabolic risk in 49/54 (91%) women with subsequent preeclampsia as treatable risk factors. Conclusion: Sequential application of a multimarker algorithm followed by determination of treatable risk factors in screen positive women is the optimal approach for first trimester preeclampsia prediction and identification of women that may benefit from targeted metabolic or cardiovascular treatment.

AB - Objective: To compare performance of multimarker algorithm, risk profiles and their sequential application in prediction of preeclampsia and determining potential intervention targets. Study Design: Maternal characteristics, ultrasound variables and serum biomarkers were collected prospectively at first trimester. Univariate analysis identified preeclampsia associated variables followed by logistic regression analysis to determine the prediction rule. Combined characteristics of the cardiovascular, metabolic and the personal risk factors were compared to the multimarker algorithm and the sequential application of both methods. Results: Out of 2433 women, 108 developed preeclampsia (4.4%). Probability scores considering nulliparity, prior preeclampsia, body mass index, diastolic blood pressure and placental growth factor had an area under the receiver operating characteristic curve 0.784 (95% CI=0.721-0.847). While the multimarker algorithm had the lowest false negative rate, sequential application of cardiovascular and metabolic risk profiles in screen positives reduced false positives by 26% and identified blood pressure and metabolic risk in 49/54 (91%) women with subsequent preeclampsia as treatable risk factors. Conclusion: Sequential application of a multimarker algorithm followed by determination of treatable risk factors in screen positive women is the optimal approach for first trimester preeclampsia prediction and identification of women that may benefit from targeted metabolic or cardiovascular treatment.

UR - http://www.scopus.com/inward/record.url?scp=84956615566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956615566&partnerID=8YFLogxK

U2 - 10.1002/pd.4707

DO - 10.1002/pd.4707

M3 - Article

VL - 36

SP - 34

EP - 39

JO - Prenatal Diagnosis

JF - Prenatal Diagnosis

SN - 0197-3851

IS - 1

ER -